(Q37378229)

20 August 2017

1 reference

title

Nail toxicity induced by cancer chemotherapy (English)

1 reference

20 August 2017

1 reference

0 references

1

Peter Gilbar

1 reference

20 August 2017

Alice Hain

2

1 reference

20 August 2017

Veta-Marie Peereboom

series ordinal

3

1 reference

20 August 2017

publication date

26 January 2009

1 reference

Journal of Oncology Pharmacy Practice

20 August 2017

published in

1 reference

20 August 2017

volume

15

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

143-155

1 reference

Drug-induced nail diseases

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Drug-induced nail disorders: incidence, management and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Drug reactions affecting the nail unit: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Malignancy and cancer treatment-related hair and nail changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Surgical anatomy of the nail apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Iatrogenic arsenic induced Mees' lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Mucocutaneous reactions to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Nail toxicity associated with epidermal growth factor receptor inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Complications of therapy and a diagnostic dilemma case. Case 2. Cutaneous toxicity induced by cetuximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Letter: Cyclophosphamide-induced nail pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Cyclophosphamide induced nail pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Taxane-induced nail changes: incidence, clinical presentation and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Nail changes due to docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Images in clinical medicine. Beau's lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Clinical picture: nail changes secondary to docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Docetaxel-induced nail dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Docetaxel-induced nail changes--a neurogenic mechanism: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Nail toxicity after treatment with docetaxel: a prospective analysis in patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Nail changes due to docetaxel--a neglected side effect and nuisance for the patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Docetaxel administration schedule: from fever to tears? A review of randomised studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Letter: Adriamycin and longitudinal pigmented banding of fingernails

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Unilateral nail changes secondary to adriamycin: the protective effect of brachial plexopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Single transverse apparent leukonychia caused by 5-fluorouracil plus leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Nail pigmentation caused by hydroxyurea: report of 9 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Mitozantrone-induced onycholysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Onycholysis secondary to multiple paclitaxel 1-hour infusions: possible role for its vehicle (Cremophor EL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Black lunula caused by Tegafur

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Topotecan induced nail pigmentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Transverse leukonychia in patients receiving cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Chemotherapy induced transverse leukonychia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155208100450

21 January 2018

Identifiers

DOI

10.1177/1078155208100450

1 reference

20 August 2017

1 reference